MetLife, Inc.

XNYSFinancials

Last traded price · USD

$99.78

−0.88%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 4 Nov 2026, 15:10 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $100.67
Volume: 5
Day's high: —
Day's low: —

In brief

MetLife, Inc. is a financials company listed on the New York Stock Exchange, valued at about $63.41B.
Its shares closed at $100.67 on 3 Nov 2026, up 27.1% over the past year.
From India you can buy MET in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy MetLife, Inc. (MET) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole MET share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade MET options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

2.9% below its 52-week high
Closed at $100.67 on 3 Nov 2026: 2.9% below the 52-week high of $103.65 (22 Oct 2026) and 49.5% above the low of $67.33 (27 Mar 2026).
Daily price bars, split-adjusted · as of 3 Nov 2026
Ahead of SPY and its sector fund XLF over 1 year
1 month: +3.9% (SPY −2.6%, XLF +6.1%). 3 months: +4.7% (SPY −2.2%, XLF −1.2%). 1 year: +27.1% (SPY +10.4%, XLF +9.7%). Price change to the 3 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: MET, SPY and XLF · as of 3 Nov 2026
Above its 50- and 200-day averages
The 3 Nov 2026 close of $100.67 was 2.8% above its 50-day average ($97.90) and 17.2% above its 200-day average ($85.92). It has closed above the 200-day for 134 sessions, since 24 Apr 2026. The 50-day average crossed above the 200-day on 5 Jun 2026, 104 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 3 Nov 2026
Short interest at 1.7% of shares outstanding
10.8M shares were sold short at the 15 Oct 2026 settlement, 1.7% of the 643.4M shares outstanding; covering them would take 3.3 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 3 Nov 2026 close

1 month+3.9%

6 months+26.0%

1 year+27.1%

5 years+54.2%

Newswire

About

MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: group benefits, retirement and income solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Investment Managenent. Group Benefits and RIS are US-based, contributing to around 52% of the firm's 2025 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 14% of 2024 earnings. The EMEA and investment management segments contributed around 6% and 3% of 2025 earnings, respectively.

Website

Notable moves

April 9, 2025
+9.97%
April 4, 2025
−9.01%
April 3, 2025
−7.98%

Newswire

About

Website

Notable moves

April 9, 2025
+9.97%
April 4, 2025
−9.01%
April 3, 2025
−7.98%

MetLife, Inc.

XNYSFinancials

Last traded price · USD

$99.78

−0.88%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 4 Nov 2026, 15:10 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $100.67
Volume: 5
Day's high: —
Day's low: —

In brief

MetLife, Inc. is a financials company listed on the New York Stock Exchange, valued at about $63.41B.
Its shares closed at $100.67 on 3 Nov 2026, up 27.1% over the past year.
From India you can buy MET in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy MetLife, Inc. (MET) shares from India?

Do I need the price of a whole MET share to invest?

How much can I invest in US stocks in a year?

Can I trade MET options or futures?

Insights

Quotes run fifteen minutes behind.

2.9% below its 52-week high
Closed at $100.67 on 3 Nov 2026: 2.9% below the 52-week high of $103.65 (22 Oct 2026) and 49.5% above the low of $67.33 (27 Mar 2026).
Daily price bars, split-adjusted · as of 3 Nov 2026
Ahead of SPY and its sector fund XLF over 1 year
1 month: +3.9% (SPY −2.6%, XLF +6.1%). 3 months: +4.7% (SPY −2.2%, XLF −1.2%). 1 year: +27.1% (SPY +10.4%, XLF +9.7%). Price change to the 3 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: MET, SPY and XLF · as of 3 Nov 2026
Above its 50- and 200-day averages
The 3 Nov 2026 close of $100.67 was 2.8% above its 50-day average ($97.90) and 17.2% above its 200-day average ($85.92). It has closed above the 200-day for 134 sessions, since 24 Apr 2026. The 50-day average crossed above the 200-day on 5 Jun 2026, 104 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 3 Nov 2026
Short interest at 1.7% of shares outstanding
10.8M shares were sold short at the 15 Oct 2026 settlement, 1.7% of the 643.4M shares outstanding; covering them would take 3.3 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 3 Nov 2026 close

1 month+3.9%

6 months+26.0%

1 year+27.1%

5 years+54.2%

Newswire

About

Website

Notable moves

April 9, 2025
+9.97%
April 4, 2025
−9.01%
April 3, 2025
−7.98%

Newswire

About

Website

Notable moves

April 9, 2025
+9.97%
April 4, 2025
−9.01%
April 3, 2025
−7.98%

MetLife, Inc.

MetLife, Inc. in brief

2.9% below its 52-week high

Ahead of SPY and its sector fund XLF over 1 year

Above its 50- and 200-day averages

Short interest at 1.7% of shares outstanding

MetLife, Inc.

MetLife, Inc. in brief

2.9% below its 52-week high

Ahead of SPY and its sector fund XLF over 1 year

Above its 50- and 200-day averages

Short interest at 1.7% of shares outstanding